"10.1371_journal.pone.0076329","plos one","2013-09-25T00:00:00Z","SeongJin Yu; Naoki Tajiri; Nick Franzese; Max Franzblau; EunKyung Bae; Simon Platt; Yuji Kaneko; Cesar V Borlongan","Department of Neurosurgery and Brain Repair, University of South Florida College of Medicine, Tampa, Florida, United States of America; Department of Small Animal Medicine & Surgery, College of Veterinary Medicine, University of Georgia, Atlanta, Georgia, United States of America","Conceived and designed the experiments: SP CVB. Performed the experiments: SY NT EB SP YK CVB. Analyzed the data: SY NT NF MF SP YK CVB. Contributed reagents/materials/analysis tools: SP CVB. Wrote the paper: SY NF MF SP YK CVB.","CVB has patents and patent applications on stem cells, their therapeutic applications and mechanisms of action. In particular, the patents and patent applications relate to the use of stem cells for treating human disorders, including the present studys target disease indication of stroke. CVB is supported by National Institutes of Health, National Institute of Neurological Disorders and Stroke 1R01NS071956-01, James and Esther King Foundation for Biomedical Research Program, SanBio Inc., Celgene Cellular Therapeutics, KMPHC and NeuralStem Inc. Senior author Dr. Cesar Borlongan is a PLoS ONE Editorial Board member. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. Patents: 1995 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders. (US patent: 6,036,951). Inventors: Sanberg, P.R., Borlongan, C.V. & Cameron, D.F. 1995 Sertoli cells as transplantation facilitator for cell transplantation. (US patent: 5,942,437). Inventors: Sanberg, P.R., Borlongan, C.V. & Cameron, D.F. 1996 Method and media for enhancing cryopreservation of cells (US patent: 6,037,175) Inventors: Sanberg, P.R., Borlongan, C.V., & Cameron, D.F. 1999 Melatonin as a protective agent against stroke. (US patent: 6,075,045). Inventors: Nishino, H. & Borlongan, C.V. 2001 Method of attenuating cognitive deficits with methanesulfonyl fluoride. (Patent pending). Inventors: Borlongan, C.V. & Moss, D. 2006 Multipotent progenitor cells rescue against stroke. (IP disclosure at MCG) Inventors: Carroll, J.E., Hess, D.C., & Borlongan, C.V. 2009 Human amnion as a source of stem cells for CNS therapy. (US Patent Pending) Inventors: Borlongan, C.V., & Parollini, O. 2009 Delta opioid peptide for stroke therapy. (US Patent Pending). Inventors: Borlongan, C.V., Su, T.-P., Wang, Y. 2010 Methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers. US patent: 7,674,457 B2. Inventors: Borlongan, C.V., and Sanberg, P.R. Senior author Dr. Cesar Borlongan is a PLOS ONE Editorial Board member. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2013","09","SeongJin Yu","SJY",8,TRUE,2,6,7,6,TRUE,TRUE,FALSE,0,NA,FALSE
